MX9709416A - Quinolizinone type compounds. - Google Patents
Quinolizinone type compounds.Info
- Publication number
- MX9709416A MX9709416A MX9709416A MX9709416A MX9709416A MX 9709416 A MX9709416 A MX 9709416A MX 9709416 A MX9709416 A MX 9709416A MX 9709416 A MX9709416 A MX 9709416A MX 9709416 A MX9709416 A MX 9709416A
- Authority
- MX
- Mexico
- Prior art keywords
- loweralkyl
- compounds
- loweralkoxy
- halo
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Antibacterial compounds having formula (I) and the pharmaceutically acceptable salts, esters and amides thereof, selected preferred examples of which include those compounds wherein A is =CR6-; R1 is cycloalkyl of from three to eight carbon atoms or substituted phenyl; R2 is selected from the group consisting of (a), (b), (c) and (d); R3 is halogen; R4 is hydrogen, loweralkyl, a pharmaceutically acceptable cation, or a prodrug ester group; R5 is hydrogen, loweralkyl, halo(loweralkyl), or -NR13R14; and R6 is halogen, loeralkyl, halo(loweralkyl), hydroxy-substituted loweralkyl, loweralkoxy(loweralkyl), loweralkoxy, or amino(loweralkyl), as well as pharmaceutical compositions containing such compounds and the use of the same in the treatment of bacterial infections.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46915995A | 1995-06-06 | 1995-06-06 | |
US63811296A | 1996-05-29 | 1996-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9709416A true MX9709416A (en) | 1998-07-31 |
Family
ID=27042662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9709416A MX9709416A (en) | 1995-06-06 | 1997-12-02 | Quinolizinone type compounds. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0871628A1 (en) |
JP (1) | JPH11510478A (en) |
KR (1) | KR19990022524A (en) |
AU (1) | AU6153096A (en) |
CA (1) | CA2222322A1 (en) |
IL (1) | IL122296A0 (en) |
MX (1) | MX9709416A (en) |
WO (1) | WO1996039407A1 (en) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0920306A2 (en) | 1996-07-12 | 1999-06-09 | Leukosite, Inc. | Chemokine receptor antagonists and methods of use therefor |
US5693813A (en) * | 1997-02-26 | 1997-12-02 | Abbott Laboratories | Process for preparation of 4H-4-oxo-quinolizine-3-carboxylic acid |
KR100241673B1 (en) * | 1997-08-09 | 2000-03-02 | 김충섭 | Quinolizine Carboxylic acid Derivatives |
EP1015445B1 (en) | 1997-09-15 | 2009-02-25 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
US6630488B1 (en) | 1998-09-21 | 2003-10-07 | Biochem Pharma, Inc. | Quinolizinones as integrin inhibitors |
ES2244248T3 (en) * | 1998-11-24 | 2005-12-01 | Daiichi Pharmaceutical Co., Ltd. | AMINOMETILPIRROLIDINE DERIVATIVES REPLACED BY CYCLALQUILOS. |
KR100768034B1 (en) | 1999-03-17 | 2007-10-17 | 다이이찌 세이야꾸 가부시기가이샤 | Pharmaceutical composition |
JP2003516988A (en) * | 1999-12-14 | 2003-05-20 | ニューロサーチ、アクティーゼルスカブ | New heteroaryl-diazabicycloalkanes |
DE19962470A1 (en) * | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Use of chemotherapy drugs |
SE0100326D0 (en) * | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
ATE404558T1 (en) * | 2001-09-28 | 2008-08-15 | Sato Pharma | ANTIMICROBIAL 4-OXOCINOLICINE COMPOUNDS THAT HAVE A 2-PYRIDONE SKELETON AS A PARTIAL STRUCTURE |
US6900224B2 (en) * | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
JP2007522093A (en) * | 2003-09-22 | 2007-08-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 7-aminoalkylidenyl-heterocyclic quinolones and naphthyridones |
EP1693364B1 (en) | 2003-12-12 | 2015-05-20 | Daiichi Sankyo Company, Limited | Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates |
US7977346B2 (en) | 2006-01-17 | 2011-07-12 | Guoqing Paul Chen | Spiro compounds and methods of use |
SMP200800058B (en) | 2006-03-28 | 2009-09-07 | Procter & Gamble | Diseased salts and polymorphs of an acid (3s, 5s) -7- [3-amino-5-methylpiperidinyl] -1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylic |
US7456279B2 (en) | 2006-03-28 | 2008-11-25 | The Procter & Gamble Company | Coupling process for preparing quinolone intermediates |
CN101622240B (en) * | 2007-01-05 | 2014-07-23 | 第一三共株式会社 | Fused substituted aminopyrrolidine derivative |
NZ577214A (en) | 2007-01-05 | 2011-11-25 | Daiichi Sankyo Co Ltd | Fused substituted aminopyrrolidine derivatives useful as antibacterial reagents |
EP2236494B1 (en) | 2007-12-26 | 2016-08-31 | Msd K.K. | Sulfonyl substituted 6-membered ring derivative |
JP5433992B2 (en) * | 2008-06-26 | 2014-03-05 | Dic株式会社 | Method for producing fluorochromanol derivative |
JP5433996B2 (en) * | 2008-07-10 | 2014-03-05 | Dic株式会社 | Method for producing fluorophenol derivative |
EP2423211B1 (en) * | 2009-04-20 | 2014-04-16 | Kaneka Corporation | Processes for producing (1s,6s)- or (1r,6r)-cis-2,8-diazabicyclo[4.3.0]nonane and intermediate thereof |
US8796297B2 (en) | 2009-06-30 | 2014-08-05 | Abbvie Inc. | 4-substituted-2-amino-pyrimidine derivatives |
WO2011031745A1 (en) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
JP5487425B2 (en) * | 2009-09-11 | 2014-05-07 | 毅 野田 | Optically active 2-substituted-3-aminopiperidine derivatives and production method |
EP2491038B1 (en) | 2009-10-23 | 2016-04-06 | Janssen Pharmaceutica N.V. | Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators |
WO2013119916A2 (en) | 2012-02-10 | 2013-08-15 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
WO2016196386A1 (en) | 2015-05-30 | 2016-12-08 | Ptc Therapeutics, Inc. | Methods for modulating rna splicing |
CN113717154A (en) | 2015-12-10 | 2021-11-30 | Ptc医疗公司 | Methods for treating huntington's disease |
MY197558A (en) | 2016-03-10 | 2023-06-23 | Janssen Pharmaceutica Nv | Methods of treating depression using orexin-2 receptor antagonists |
CN106543170B (en) * | 2016-10-27 | 2018-02-23 | 丹诺医药(苏州)有限公司 | The carboxylate of 8 chlorine, 1 cyclopropyl, 7 fluorine, 9 methyl, 4 oxygen, 4 hydrogen quinolizine 3 and its synthetic method |
US11702646B2 (en) | 2016-11-28 | 2023-07-18 | Ptc Therapeutics, Inc. | Methods for modulating RNA splicing |
WO2018226622A1 (en) | 2017-06-05 | 2018-12-13 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
CN111372611A (en) | 2017-06-14 | 2020-07-03 | Ptc医疗公司 | Methods of modifying RNA splicing |
BR112019027717A2 (en) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics, Inc. | methods to treat huntington's disease |
EP3645121A4 (en) | 2017-06-28 | 2021-03-17 | PTC Therapeutics, Inc. | Methods for treating huntington's disease |
KR20210005559A (en) | 2018-03-27 | 2021-01-14 | 피티씨 테라퓨틱스, 인크. | Huntington's Disease Treatment Compound |
WO2020005882A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
CA3103976A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heterocyclic and heteroaryl compounds for treating huntington's disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE911472A1 (en) * | 1990-05-02 | 1991-11-06 | Abbott Lab | Quinolizinone type compounds |
ATE217309T1 (en) * | 1993-10-14 | 2002-05-15 | Abbott Lab | QUINOLIZINONE TYPE COMPOUNDS |
-
1996
- 1996-06-05 IL IL12229696A patent/IL122296A0/en unknown
- 1996-06-05 CA CA002222322A patent/CA2222322A1/en not_active Abandoned
- 1996-06-05 EP EP96919103A patent/EP0871628A1/en not_active Withdrawn
- 1996-06-05 AU AU61530/96A patent/AU6153096A/en not_active Abandoned
- 1996-06-05 KR KR1019970709005A patent/KR19990022524A/en not_active Application Discontinuation
- 1996-06-05 JP JP9501420A patent/JPH11510478A/en active Pending
- 1996-06-05 WO PCT/US1996/008991 patent/WO1996039407A1/en not_active Application Discontinuation
-
1997
- 1997-12-02 MX MX9709416A patent/MX9709416A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1996039407A1 (en) | 1996-12-12 |
KR19990022524A (en) | 1999-03-25 |
AU6153096A (en) | 1996-12-24 |
JPH11510478A (en) | 1999-09-14 |
EP0871628A1 (en) | 1998-10-21 |
IL122296A0 (en) | 1998-04-05 |
CA2222322A1 (en) | 1996-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9709416A (en) | Quinolizinone type compounds. | |
DE69430581D1 (en) | CHINOLIZINONE TYPE COMPOUNDS | |
NZ325837A (en) | Carbamoyloxy derivatives of mutiline and their use as antibacterials | |
BG105543A (en) | Novel macrolide antibiotics | |
HUT56073A (en) | Process for producing perhydroisoquinoline amino acid derivatives and pharmaceutical compositions comprising same | |
MX9803650A (en) | Benzoxazine antimicrobial agents. | |
HUT71584A (en) | Lipopeptide derivatives and pharmaceutical compositions containing them | |
AP2001002222A0 (en) | Ketolide antibiotics. | |
GT199900208A (en) | CARBAMATO AND CARBAZATO CETÒLID ANTIBIOTICS. | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
AU4696897A (en) | Neurotrophin antagonist compositions | |
HUP0100470A2 (en) | Oxazolidinone derivatives and pharmaceutical compositions containing them | |
DZ2242A1 (en) | Carbapenem antibiotic, compositions and method of preparation. | |
NZ308518A (en) | Antibacterial cephalosporins | |
PT1132392E (en) | ANTIBIOTICS CETOLIDOS | |
GR3036873T3 (en) | Dialkyltiacumicin compounds | |
ZA93494B (en) | Napthalene amides and sulphonamides, processes for their preparation and pharmaceutical compositions containing them | |
HUT64071A (en) | Process for producing antimicrobial carbapenem derivatives and pharmaceutical compositions comprising such compounds | |
YU66900A (en) | Hygromycin a derivatives | |
CA2351829A1 (en) | Macrolide antibiotics | |
AP2001002154A0 (en) | Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents. | |
YU64300A (en) | 2"-deoxy hygromycin derivatives | |
MXPA02011966A (en) | Hygromycin a derivatives for the treatment of bacterial and protozoal infections. | |
EP1023062A4 (en) | Antibacterial carbapenems, compositions and methods of treatment | |
AP2002002492A0 (en) | Hygromycin a prodrugs. |